AN2 Therapeutics, Inc. (ANTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XHAM $
4. 68
+0.01
+0.2141%
$
130.43M Market Cap
- P/E Ratio
- Div Yield
66,100 Volume
- Eps
$ 4.67
Previous Close 
Want to track ANTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AN2 Therapeutics, Inc. (ANTX) Statistics
Valuation metrics
Market Cap 130.43M
Enterprise value 74.75M
Trailing P/E (ttm) -4.25
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) -
Price/Book (mrq) 1.95
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.09
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 57.38K
Average volume (90 days) 235.66K
Price summary
52-Week low 1
52-Week high 6.91
Beta -
50-Day moving average 4.74
200-Day moving average 2.91
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.39%
Return on equity -0.52%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.5
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 15.73%
Book value per share (mrq) 2.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
